{"": [95, 466, 0, 467, 1058, 0, 1059, 2260, 0, 2261, 2411, 0], "Background": [2412, 6951, 0], "Participants": [6961, 8592, 0], "Statistical Analysis": [8593, 9674, 0], "Methods": [6952, 9674, 1], "Demographic Characteristic of the Studied Subjects": [9684, 10383, 0], "Correlation Between the Severity of Post-vaccinal Reaction and Different Parameters": [10384, 11474, 0], "Post-vaccinal Adverse Effects Following Administration of BNT162b2 or ChAdOx1": [11475, 14189, 0], "Post-vaccinal Adverse Effects Following Administration of First and Second Doses of BNT162b2": [14190, 15274, 0], "Uncommon Post-vaccinal Adverse Effects Added by the Participants": [15275, 16002, 0], "Results": [9675, 16002, 1], "Discussion": [16003, 21522, 0], "Limitation of the Study": [22080, 22798, 0], "Conclusion": [21523, 22798, 1], "Data Availability Statement": [22799, 22995, 0], "Ethics Statement": [22996, 23158, 0], "Author Contributions": [23159, 23438, 0], "Funding": [23439, 23544, 0], "Conflict of Interest": [23545, 23740, 0], "Publisher's Note": [23741, 24106, 0]}